The Recall Desk

Hazard

Glass Particulates recalls

11 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
11
Critical
1
Severe
8
Most recent
2024-02-28

Of the 11 glass particulates recalls we have scored against our rubric, 1 (9%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 8 (73%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all glass particulates recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

1–11 of 11

  • HighFDA (Drugs)·D-0332-2024·2024-02-28

    Equate Cherry Cough Drops recalled for potential glass and silicone contamination

    Bestco LLC is recalling Equate Cherry Cough Drops nationwide due to potential glass and silicone particulates from manufacturing deviations. Affected products are 30-drop and 160-drop bags expiring December 31, 2026.

    Product
    Equate Cherry Cough Drops, Menthol cough suppressant/Oral Anesthetic, a) 30 drops per bag, item number 20000462, b) 160 drops per bag, item number 20000463, Bestco, 288 Mazeppa Road, Mooresville, NC 28115
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0561-2020·2019-12-11

    QuVa Pharma Recalls Fentanyl and Ropivacaine Bags Due to Glass Particulates

    QuVa Pharma is recalling specific lots of fentanyl and ropivacaine injection bags due to the presence of glass particulates.

    Product
    fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride , 100 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1108-36
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0567-2020·2019-12-11

    QuVa Pharma Recalls Fentanyl Injection Bags Due to Glass Particulates

    QuVa Pharma is recalling fentanyl injection bags due to the potential presence of glass particulates.

    Product
    fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1444-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0568-2020·2019-12-11

    QuVa Pharma Recalls Fentanyl and Bupivacaine Infusion Due to Glass Particulates

    QuVa Pharma is recalling specific lots of a fentanyl and bupivacaine infusion due to the presence of glass particulates.

    Product
    fentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 mg/200 mL (1.667 mg/mL) in 0.9% Sodium Chloride 200 mL in 250 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1436-76
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1073-2019·2019-04-10

    Pfizer Recalls Sodium Bicarbonate Injection Vials Due to Glass Particulates

    Pfizer is recalling 8.4% Sodium Bicarbonate Injection vials because they contain glass particulates. The recall covers 283,400 vials distributed in the United States and Puerto Rico.

    Product
    8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-764-2014·2014-01-29

    Cubicin Injection Recalled for Glass Particulates in Vials

    Cubist Pharmaceuticals is recalling 179,870 vials of Cubicin (daptomycin for injection) due to the presence of glass particulates.

    Product
    Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-135-2013·2013-01-30

    Genentech Recalls Trastuzumab Kits Due to Potential Glass Particulates

    Genentech is recalling 2,140 Trastuzumab Kits for investigational use because the included Bacteriostatic Water for Injection diluent vials may contain glass particulates.

    Product
    Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple dose vial Bacteriostatic Water for Injection, USP (1.1% benzyl alcohol), Manufactured by Hospira, Inc., for Genentech, Inc., South San Francisco, CA 94080-4990, NDC 50242-903-69; and 1 Reco
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-106-2013·2013-01-09

    Hospira Recalls Epinephrine Injection Due to Potential Glass Particulates

    Hospira is recalling specific lots of Epinephrine Injection USP because they may contain glass particles.

    Product
    Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-070-2013·2012-12-05

    Ranbaxy Recalls Atorvastatin Calcium Tablets Due to Glass Particulates

    Ranbaxy Inc. is recalling certain lots of Atorvastatin Calcium tablets because they may contain small glass particulates.

    Product
    ATORVASTATIN CALCIUM — ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
    Category
    Drug
    Distribution
    Distributed nationwide